NOD/Shi-scid IL2rγnull (NOG) mice more appropriate for humanized mouse models

Current Topics in Microbiology and Immunology

Volumn 324, Issue , 2008, Pages 53-76

  Ito, M ^a   Kobayashi, K ^b   Nakahata, T ^c  

^a CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^b RIKEN   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR GAMMA; RAG2 PROTEIN; DNA BINDING PROTEIN; IL2RG PROTEIN, MOUSE; RAG2 PROTEIN, MOUSE;

BAGG ALBINO MOUSE; CANCER MODEL; CANCER STEM CELL; CD34 SELECTION; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; COMBINED IMMUNODEFICIENCY; CONGENIC STRAIN; DENDRITIC CELL; DISEASE MODEL; GENE EXPRESSION; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INBRED STRAIN; INNATE IMMUNITY; MOUSE STRAIN; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCID MOUSE; SEVERE COMBINED IMMUNODEFICIENCY; THYMOMA; TRANSGENIC MOUSE; XENOGRAFT; ANIMAL; JAPAN; MOUSE; MOUSE MUTANT; NONOBESE DIABETIC MOUSE;

MUS;

ANIMALS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; HUMANS; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; JAPAN; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, SCID;

EID: 44449120863     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-75647-7_3     Document Type: Review

References (116)

1. Bach, E. A., M. Aguet, and R. D. Schreiber. 1997. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 15:563-591.
2. -/- mice. Proc Natl Acad Sci USA 103:15951-15956.
3. Behringer, R. R., L. S. Mathews, R. D. Palmiter, and R. L. Brinster. 1988. Dwarf mice produced by genetic ablation of growth hormone-expressing cells. Genes Dev 2:453-461.
4. -/- (RAG-hu) mouse model. Retrovirology 3:76.
5. Berning, A. K., E. M. Eicher, W. E. Paul, and I. Scher. 1980. Mapping of the X-linked immune deficiency mutation (xid) of CBA/N mice. J Immunol 124:1875-1877.
6. Bock, T. A., D. Orlic, C. E. Dunbar, H. E. Broxmeyer, and D. M. Bodine. 1995. Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes. J Exp Med 182:2037-2043.
7. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-gamma. Annu Rev Immunol 15:749-795.
8. Bosma, G. C., R. P. Custer, and M. J. Bosma. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301:527-530.
9. Bosma, M. J. 1992. B and T cell leakiness in the scid mouse mutant. Immunodeficiency Rev 3:261-276.
10. Camacho, R. E., R. Wnek, K. Shah, D. M. Zaller, R. J. O'Reilly, N. Collins, P. Fitzgerald-Bocarsly, and G. C. Koo. 2004. Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenic NOD/scid mice. Cell Immunol 232:86-95.
11. Cao, X., E. W. Shores, J. Hu-Li, M. R. Anver, B. L. Kelsall, S. M. Russell, J. Drago, M. Noguchi, A. Grinberg, E. T. Bloom et al. 1995. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2:223-238.
12. Chan, C. W., E. Crafton, H. N. Fan, J. Flook, K. Yoshimura, M. Skarica, D. Brockstedt, T. W. Dubensky, M. F. Stins, L. L. Lanier, D. M. Pardoll, and F. Housseau. 2006. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat Med 12:207-213.
13. Christianson, S. W., D. L. Greiner, R. A. Hesselton, J. H. Leif, E. J. Wagar, I. B. Schweitzer, T. V. Rajan, B. Gott, D. C. Roopenian, and L. D. Shultz. 1997. Enhanced human CD4+ T cell engraftment in beta2-microglobulin- deficient NOD-scid mice. J Immunol 158:3578-3586.
14. Christianson, S. W., D. L. Greiner, I. B. Schweitzer, B. Gott, G. L. Beamer, P. A. Schweitzer, R. M. Hesselton, and L. D. Shultz. 1996. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice. Cell immunol 171:186-199.
15. Custer, R. P., G. C. Bosma, and M. J. Bosma. 1985. Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms. Am J Pathol 120:464-477.
16. null mice: suppression by an Inhibitor against NF-kappaB. J Virol 77:5286-5294.
17. Dewan, M. Z., J. N. Uchihara, K. Terashima, M. Honda, T. Sata, M. Ito, N. Fujii, K. Uozumi, K. Tsukasaki, M. Tomonaga, Y. Kubuki, A. Okayama, M. Toi, N. Mori, and N. Yamamoto. 2006. Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir. Blood 107:716-724.
18. Dewan, M. Z., M. Watanabe, S. Ahmed, K. Terashima, S. Horiuchi, T. Sata, M. Honda, M. Ito, T. Watanabe, R. Horie, and N. Yamamoto. 2005. Hodgkin's lymphoma cells are efficiently engrafted and tumor marker CD30 is expressed with constitutive nuclear factor-kappaB activity in unconditioned NOD/SCID/γc mice. Cancer Sci 96:466-473.
19. null mice. Cancer Sci 95:564-568.
20. Dick, J. E. 1996. Human stem cell assays in immune-deficient mice. Curr Opin Hematol 3:405-409.
21. Dick, J. E., C. Sirard, F. Pflumio, and T. Lapidot. 1992. Murine models of normal and neoplastic human haematopoiesis. Cancer Surveys 15:161-181.
22. DiSanto, J. P., W. Muller, D. Guy-Grand, A. Fischer, and K. Rajewsky. 1995. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci USA 92:377-381.
23. Doshi, M., M. Koyanagi, M. Nakahara, K. Saeki, K. Saeki, and A. Yuo. 2006. Identification of human neutrophils during experimentally induced inflammation in mice with transplanted CD34+ cells from human umbilical cord blood. Int J Hematol 84:231-237.
24. Fu, Y. X., H. Molina, M. Matsumoto, G. Huang, J. Min, and D. D. Chaplin. 1997. Lymphotoxin-alpha (LTα) supports development of splenic follicular structure that is required for IgG responses. J Exp Med 185:2111-2120.
25. Fugmann, S. D., A. I. Lee, P. E. Shockett, I. J. Villey, and D. G. Schatz. 2000. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu Rev Immunol 18:495-527.
26. null mice through cell fusion. FASEB J. in press.
27. -/- mice: functional inactivation of p53 in developing T cells. Blood 104:3886-3893.
28. Giovanella, B. C., and J. Fogh. 1985. The nude mouse in cancer research. Adv Cancer Res 44:69-120.
29. Goldman, J. P., M. P. Blundell, L. Lopes, C. Kinnon, J. P. Di Santo, and A. J. Thrasher. 1998. Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Br J Haematol 103:335-342.
30. -/- mice. J Virol 81:2700-2712.
31. Greiner, D. L., R. A. Hesselton, and L. D. Shultz. 1998. SCID mouse models of human stem cell engraftment. Stem Cells (Dayton, Ohio) 16:166-177.
32. Habu, S., H. Fukui, K. Shimamura, M. Kasai, Y. Nagai, K. Okumura, and N. Tamaoki. 1981. In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J Immunol 127:34-38.
33. Hesselton, R. M., D. L. Greiner, J. P. Mordes, T. V. Rajan, J. L. Sullivan, and L. D. Shultz. 1995. High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice. J Infect Dis 172:974-982.
34. Heyman, R. A., E. Borrelli, J. Lesley, D. Anderson, D. D. Richman, S. M. Baird, R. Hyman, and R. M. Evans. 1989. Thymidine kinase obliteration: creation of transgenic mice with controlled immune deficiency. Proc Natl Acad Sci USA 86:2698-2702.
35. Hill, A. V. 1998. The immunogenetics of human infectious diseases. Annu Rev Immunol 16:593-617.
36. Hioki, K., T. Kuramochi, S. Endoh, E. Terada, Y. Ueyama, and M. Ito. 2001. Lack of B cell leakiness in BALB/cA-nu, scid double mutant mice. Exp Anim 50:67-72.
37. null mice model. Blood 102:873-880.
38. Ikebe, M., K. Miyakawa, K. Takahashi, K. Ohbo, M. Nakamura, K. Sugamura, T. Suda, K. Yamamura, and K. Tomita. 1997. Lymphohaematopoietic abnormalities and systemic lymphoproliferative disorder in interleukin-2 receptor gamma chain-deficient mice. Int J Exp Pathol 78:133-148.
39. Isaacson, J. H., and B. M. Cattanach. 1962. Report. Mouse News Letter 27:31.
40. null mice. Blood 106:1565-1573.
41. null mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100:3175-3182.
42. Jacobs, H., P. Krimpenfort, M. Haks, J. Allen, B. Blom, C. Demolliere, A. Kruisbeek, H. Spits, and A. Berns. 1999. PIM1 reconstitutes thymus cellularity in interleukin 7- and common gamma chain-mutant mice and permits thymocyte maturation in Rag- but not CD3gamma-deficient mice. J Exp Med 190:1059-1068.
43. + T cells by exogenous cell-associated antigens. Immunity 17:211-220.
44. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31-37.
45. Kambe, N., H. Hiramatsu, M. Shimonaka, H. Fujino, R. Nishikomori, T. Heike, M. Ito, K. Kobayashi, Y. Ueyama, N. Matsuyoshi, Y. Miyachi, and T. Nakahata. 2004. Development of both human connective tissue-type and mucosal-type mast cells in mice from hematopoietic stem cells with identical distribution pattern to human body. Blood 103:860-867.
46. Kamel-Reid, S., and J. E. Dick. 1988. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 242:1706-1709.
47. Kamogawa, Y., L. A. Minasi, S. R. Carding, K. Bottomly, and R. A. Flavell. 1993. The relationship of IL-4- and IFN gamma-producing T cells studied by lineage ablation of IL-4-producing cells. Cell 75:985-995.
48. Kasai, M., M. Iwamori, Y. Nagai, K. Okumura, and T. Tada. 1980. A glycolipid on the surface of mouse natural killer cells. Eur J Immunol 10:175-180.
49. Kelly, E. M. 1957. Report. Mouse News Letter 16:36.
50. Kikutani, H., and S. Makino. 1992. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 51:285-322.
51. Kirberg, J., A. Berns, and H. von Boehmer. 1997. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med 186:1269-1275.
52. Kirchgessner, C. U., C. K. Patil, J. W. Evans, C. A. Cuomo, L. M. Fried, T. Carter, M. A. Oettinger, and J. M. Brown. 1995. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 267:1178-1183.
53. Koyanagi, Y., Y. Tanaka, J. Kira, M. Ito, K. Hioki, N. Misawa, Y. Kawano, K. Yamasaki, R. Tanaka, Y. Suzuki, Y. Ueyama, E. Terada, T. Tanaka, M. Miyasaka, T. Kobayashi, Y. Kumazawa, and N. Yamamoto. 1997. Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain. J Virol 71:2417-2424.
54. Kuroiwa, Y., H. Yoshida, T. Ohshima, T. Shinohara, A. Ohguma, Y. Kazuki, M. Oshimura, I. Ishida, and K. Tomizuka. 2002. The use of chromosome-based vectors for animal transgenesis. Gene Therapy 9:708-712.
55. Lander, E. S., L. M. Linton, B. Birren, C. Nusbaum, M. C. Zody et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
56. Linder, C. C. 2006. Genetic variables that influence phenotype. ILAR J 47:132-140.
57. Lowry, P. A., L. D. Shultz, D. L. Greiner, R. M. Hesselton, E. L. Kittler, C. Y. Tiarks, S. S. Rao, J. Reilly, J. H. Leif, H. Ramshaw, F. M. Stewart, and P. J. Quesenberry. 1996. Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients. Biol Blood Marrow Transplant 2:15-23.
58. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29:1-13.
59. Markel, P., P. Shu, C. Ebeling, G. A. Carlson, D. L. Nagle, J. S. Smutko, and K. J. Moore. 1997. Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains. Nat Genet 17:280-284.
60. null immunodeficient mice. Proc Natl Acad Sci USA 104:1925-1930.
61. null (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD34+ cells. Exp Hematol 31:789-797.
62. Matsuura-Sawada, R., T. Murakami, Y. Ozawa, H. Nabeshima, J. Akahira, Y. Sato, Y. Koyanagi, M. Ito, Y. Terada, and K. Okamura. 2005. Reproduction of menstrual changes in transplanted human endometrial tissue in immunodeficient mice. Hum Reprod 20:1477-1484.
63. Mazurier, F., M. Doedens, O. I. Gan, and J. E. Dick. 2003. Characterization of cord blood hematopoietic stem cells. Ann NY Acad Sci 996:67-71.
64. McCune, J. M., R. Namikawa, H. Kaneshima, L. D. Shultz, M. Lieberman, and I. L. Weissman. 1988. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632-1639.
65. Melkus, M. W., J. D. Estes, A. Padgett-Thomas, J. Gatlin, P. W. Denton, F. A. Othieno, A. K. Wege, A. T. Haase, and J. V. Garcia. 2006. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 12:1316-1322.
66. Meuleman, P., L. Libbrecht, R. De Vos, B. de Hemptinne, K. Gevaert, J. Vandekerckhove, T. Roskams, and G. Leroux-Roels. 2005. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology 41:847-856.
67. Miller, R. D., J. Hogg, J. H. Ozaki, D. Gell, S. P. Jackson, and R. Riblet. 1995. Gene for the catalytic subunit of mouse DNA-dependent protein kinase maps to the scid locus. Proc Natl Acad Sci USA 92:10792-10795.
68. Miyakawa, Y., Fukuchi, Y., Ito, M., Kobayashi, K., Kuramochi, T., Ikeda, Y., Takebe, Y., Tanaka, T., Miyasaka, M., Tanaka, N., Tamaoki, N., Nomura, T., Ueyama, Y., Shimamura, K. 1996. Establishment of human granulocyte-macrophage colony stimulating factor produing transgenic SCID mice. Br J Haematol 95:437-442.
69. null (NOG) mice. Biochem Biophys Res Commun 313:258-262.
70. Mombaerts, P., J. Iacomini, R. S. Johnson, K. Herrup, S. Tonegawa, and V. E. Papaioannou. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869-877.
71. Mosier, D. E., R. J. Gulizia, S. M. Baird, S. Spector, D. Spector, T. J. Kipps, R. I. Fox, D. A. Carson, N. Cooper, D. D. Richman et al. 1989. Studies of HIV infection and the development of Epstein-Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency. Curr Top Microbiol Immunol 152:195-199.
72. Mosier, D. E., R. J. Gulizia, S. M. Baird, and D. B. Wilson. 1988. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256-259.
73. Muguruma, Y., T. Yahata, H. Miyatake, T. Sato, T. Uno, J. Itoh, S. Kato, M. Ito, T. Hotta, and K. Ando. 2006. Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment. Blood 107:1878-1887.
74. Mule, J. J., D. L. Jicha, P. M. Aebersold, W. D. Travis, and S. A. Rosenberg. 1991. Disseminated human malignant melanoma in congenitally immune-deficient (bg/nu/xid) mice. J NCI 83:350-355.
75. Nakamura, T., Y. Miyakawa, A. Miyamura, A. Yamane, H. Suzuki, M. Ito, Y. Ohnishi, N. Ishiwata, Y. Ikeda, and N. Tsuruzoe. 2006. A novel nonpeptidyl human c-Mpl activator stimulates human megakaryopoiesis and thrombopoiesis. Blood 107:4300-4307.
76. Nakata, H., K. Maeda, T. Miyakawa, S. Shibayama, M. Matsuo, Y. Takaoka, M. Ito, Y. Koyanagi, and H. Mitsuya. 2005. Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse model. J Virol 79:2087-2096.
77. Ninomiya, M., A. Abe, T. Yokozawa, K. Ozeki, K. Yamamoto, M. Ito, H. Kiyoi, N. Emi, and T. Naoe. 2006. Establishment of a myeloid leukemia cell line, TRL-01, with MLL-ENL fusion gene. Cancer Genet Cytogenet 169:1-11.
78. Ohbo, K., T. Suda, M. Hashiyama, A. Mantani, M. Ikebe, K. Miyakawa, M. Moriyama, M. Nakamura, M. Katsuki, K. Takahashi, K. Yamamura, and K. Sugamura. 1996. Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain. Blood 87:956-967.
79. + lymphoid dendritic cells. J Exp Med 189:1981-1986.
80. Passegue, E., C. H. Jamieson, L. E. Ailles, and I. L. Weissman. 2003. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci USA 100 Suppl 1:11842-11849.
81. Pearson, T., D. L. Greiner, and L. D. Shultz. 2007. Humanized SCID mouse models for biomedical research. This volume.
82. Pflumio, F., B. Izac, A. Katz, L. D. Shultz, W. Vainchenker, and L. Coulombel. 1996. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood 88:3731-3740.
83. Prochazka, M., H. R. Gaskins, L. D. Shultz, and E. H. Leiter. 1992. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci USA 89:3290-3294.
84. Rao, M. K., and M. F. Wilkinson. 2006. Tissue-specific and cell type-specific RNA interference in vivo. Nat Proto 1:1494-1501.
85. Saito, M., T. Iwawaki, C. Taya, H. Yonekawa, M. Noda, Y. Inui, E. Mekada, Y. Kimata, A. Tsuru, and K. Kohno. 2001. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat Biotechnol 19:746-750.
86. Seibler, J., A. Kleinridders, B. Kuter-Luks, S. Niehaves, J. C. Bruning, and F. Schwenk. 2007. Reversible gene knockdown in mice using a tight, inducible shRNA expression system. Nucleic Acids Res 35:e54.
87. Seita, J., H. Ema, J. Ooehara, S. Yamazaki, Y. Tadokoro, A. Yamasaki, K. Eto, S. Takaki, K. Takatsu, and H. Nakauchi. 2007. Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction. Proc Natl Acad Sci USA 104:2349-2354.
88. Shinkai, Y., G. Rathbun, K. P. Lam, E. M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. M. Stall, et al. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68:855-867.
89. Shresta, S., D. M. MacIvor, J. W. Heusel, J. H. Russell, and T. J. Ley. 1995. Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc Natl Acad Sci USA 92:5679-5683.
90. null mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment. Transplantation 76:1036-1042.
91. Shultz, L. D., F. Ishikawa, and D. L. Greiner. 2007. Humanized mice in translational biomedical research. Nat Rev 7:118-130.
92. Shultz, L. D., B. L. Lyons, L. M. Burzenski, B. Gott, X. Chen, S. Chaleff, M. Kotb, S. D. Gillies, M. King, J. Mangada, D. L. Greiner, and R. Handgretinger. 2005. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174:6477-6489.
93. Shultz, L. D., P. A. Schweitzer, S. W. Christianson, B. Gott, I. B. Schweitzer, B. Tennent, S. McKenna, L. Mobraaten, T. V. Rajan, D. L. Greiner et al. 1995. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 154:180-191.
94. Steinsvik, T. E., P. I. Gaarder, I. S. Aaberge, and Lovik. 1995. Engraftment and humoral immunity in SCID and RAG-2-deficient mice transplanted with human peripheral blood lymphocytes. Scand J Immunol 42:607-616.
95. Suematsu, S., and T. Watanabe. 2004. Generation of a synthetic lymphoid tissue-like organoid in mice. Nat Biotechnol 22:1539-1545.
96. null (NOG) mice. Int J Oncol 31:741-751..
97. Sugamura, K., H. Asao, M. Kondo, N. Tanaka, N. Ishii, K. Ohbo, M. Nakamura, and T. Takeshita. 1996. The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu Rev Immunol 14:179-205.
98. Suwa, H., T. Tanaka, F. Kitamura, T. Shiohara, K. Kuida, and M. Miyasaka. 1995. Dysregulated expression of the IL-2 receptor beta-chain abrogates development of NK cells and Thy-1+ dendritic epidermal cells in transgenic mice. Int Immunol 7:1441-1449.
99. Taieb, J., N. Chaput, C. Menard, L. Apetoh, E. Ullrich, M. Bonmort, M. Pequignot, N. Casares, M. Terme, C. Flament, P. Opolon, Y. Lecluse, D. Metivier, E. Tomasello, E. Vivier, F. Ghiringhelli, F. Martin, D. Klatzmann, T. Poynard, T. Tursz, G. Raposo, H. Yagita, B. Ryffel, G. Kroemer, and L. Zitvogel. 2006. A novel dendritic cell subset involved in tumor immunosurveillance. Nat Med 12:214-219.
100. Tanaka, T., F. Kitamura, Y. Nagasaka, K. Kuida, H. Suwa, and M. Miyasaka. 1993. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice. J Exp Med 178:1103-1107.
101. Tateno, C., Y. Yoshizane, N. Saito, M. Kataoka, R. Utoh, C. Yamasaki, A. Tachibana, Y. Soeno, K. Asahina, H. Hino, T. Asahara, T. Yokoi, T. Furukawa, and K. Yoshizato. 2004. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 165:901-912.
102. Torbett, B. E., G. Picchio, and D. E. Mosier. 1991. hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis. Immunol Rev 124:139-164.
103. Traggiai, E., L. Chicha, L. Mazzucchelli, L. Bronz, J. C. Piffaretti, A. Lanzavecchia, and M. G. Manz. 2004. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304:104-107.
104. + cells in NOD/Shi-scid mice. Stem Cells (Dayton, Ohio) 18:204-213.
105. Warner, J. K., J. C. Wang, K. J. Hope, L. Jin, and J. E. Dick. 2004. Concepts of human leukemic development. Oncogene 23:7164-7177.
106. Watanabe, S., K. Terashima, S. Ohta, S. Horibata, M. Yajima, Y. Shiozawa, M. Z. Dewan, Z. Yu, M. Ito, T. Morio, N. Shimizu, M. Honda, and N. Yamamoto. 2007. Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood 109:212-218.
107. Waterston, R. H., K. Lindblad-Toh, E. Birney, J. Rogers, J. F. Abril, P. Agarwal, R. Agarwala et al. 2002. Initial sequencing and comparative analysis of the mouse genome. Nature 420:520-562.
108. Widney, D. P., Y. R. Xia, A. J. Lusis, and J. B. Smith. 2000. The murine chemokine CXCL11 (IFN-inducible T cell alpha chemoattractant) is an IFN-gamma- and lipopolysaccharide-inducible glucocorticoid-attenuated response gene expressed in lung and other tissues during endotoxemia. J Immunol 164:6322-6331.
109. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 17:255-281.
110. Wong, G. T. 2002. Speed congenics: applications for transgenic and knock-out mouse strains. Neuropeptides 36:230-236.
111. null mice. Mol Ther 10:882-891.
112. Yahata, T., K. Ando, Y. Nakamura, Y. Ueyama, K. Shimamura, N. Tamaoki, S. Kato, and T. Hotta. 2002. Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice. J Immunol 169:204-209.
113. Yahata, T., S. Yumino, Y. Seng, H. Miyatake, T. Uno, Y. Muguruma, M. Ito, H. Miyoshi, S. Kato, T. Hotta, and K. Ando. 2006. Clonal analysis of thymus-repopulating cells presents direct evidence for self-renewal division of human hematopoietic stem cells. Blood 108:2446-2454.
114. Yamazaki, S., A. Iwama, Y. Morita, K. Eto, H. Ema, and H. Nakauchi. 2007. Cytokine signaling, lipid raft clustering, and HSC hibernation. Ann NY Acad Sci 1106:54-63.
115. Yoshino, H., T. Ueda, M. Kawahata, K. Kobayashi, Y. Ebihara, A. Manabe, R. Tanaka, M. Ito, S. Asano, T. Nakahata, and K. Tsuji. 2000. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice. Bone Marrow Transplant 26:1211-1216.
116. Zijlstra, M., E. Li, F. Sajjadi, S. Subramani, and R. Jaenisch. 1989. Germ-line transmission of a disrupted beta 2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature 342:435-438.